Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1998 2
1999 3
2000 1
2001 6
2002 2
2003 4
2004 2
2005 1
2006 3
2007 5
2008 5
2009 2
2010 3
2011 3
2013 4
2014 3
2015 5
2016 9
2017 9
2018 10
2019 8
2020 1
2021 6
2022 7
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Aktualisierte S2k-Leitlinie Zöliakie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Felber J, Bläker H, Fischbach W, Koletzko S, Laaß M, Lachmann N, Lorenz P, Lynen P, Reese I, Scherf K, Schuppan D, Schumann M, Aust D, Baas S, Beisel S, de Laffolie J, Duba E, Holtmeier W, Lange L, Loddenkemper C, Moog G, Rath T, Roeb E, Rubin D, Stein J, Török H, Zopf Y. Felber J, et al. Z Gastroenterol. 2022 May;60(5):790-856. doi: 10.1055/a-1741-5946. Epub 2022 May 11. Z Gastroenterol. 2022. PMID: 35545109 Free article. German. No abstract available.
C-kit, GIST, and imatinib.
Siehl J, Thiel E. Siehl J, et al. Recent Results Cancer Res. 2007;176:145-51. doi: 10.1007/978-3-540-46091-6_12. Recent Results Cancer Res. 2007. PMID: 17607922 Review.
A gain-of-function mutation of c-kit is the crucial step in tumorigenesis of gastrointestinal stromal tumors (GIST). Imatinib can block the activated receptor tyrosine kinase activity of c-kit. These findings made GIST an ideal candidate for evaluation of new target …
A gain-of-function mutation of c-kit is the crucial step in tumorigenesis of gastrointestinal stromal tumors (GIST). Imatinib can blo …
Understanding Braess' Paradox in power grids.
Schäfer B, Pesch T, Manik D, Gollenstede J, Lin G, Beck HP, Witthaut D, Timme M. Schäfer B, et al. Nat Commun. 2022 Sep 14;13(1):5396. doi: 10.1038/s41467-022-32917-6. Nat Commun. 2022. PMID: 36104335 Free PMC article.
Interview with Prof. Dr. Benjamin List: Nobel Laureate in Chemistry 2021.
Dilanas MEA, Dobbelaar E, Gerischer CM, Haseloer A, John T, Neumeier C. Dilanas MEA, et al. Chemistry. 2022 Aug 4;28(44):e202201236. doi: 10.1002/chem.202201236. Epub 2022 Jul 12. Chemistry. 2022. PMID: 35820153
In an interview with Benjamin List, winner of the 2021 Nobel Prize in Chemistry, members of the Young Chemists' Network (JCF) of the German Chemical Society (GDCh) asked him about his science, his career, and the academic system. Benjamin List, Director at the Max-P …
In an interview with Benjamin List, winner of the 2021 Nobel Prize in Chemistry, members of the Young Chemists' Network (JCF) of the …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2024 May;14(4_suppl):690S-714S. doi: 10.1177/21925682241245615. Global Spine J. 2024. PMID: 38726630 Free PMC article. No abstract available.
Imatinib resistance in gastrointestinal stromal tumors.
Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS. Chen LL, et al. Curr Oncol Rep. 2005 Jul;7(4):293-9. doi: 10.1007/s11912-005-0053-6. Curr Oncol Rep. 2005. PMID: 15946589 Review.
Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous le …
Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, a …
New developments in gastrointestinal stromal tumor.
Trent JC, Benjamin RS. Trent JC, et al. Curr Opin Oncol. 2006 Jul;18(4):386-95. doi: 10.1097/01.cco.0000228747.02660.e2. Curr Opin Oncol. 2006. PMID: 16721136 Review.
RECENT FINDINGS: Over the past 60 years basic scientists, pathologists and clinical investigators have studied gastrointestinal stromal tumor with no major advances in patient care until the late 1990s. Discovery at that time of the critical biological role of Kit in gastr …
RECENT FINDINGS: Over the past 60 years basic scientists, pathologists and clinical investigators have studied gastrointestinal stromal tumo …
105 results